REGIMENTED PHOSPHODIESTERASE TYPE 5 INHIBITOR USE REDUCES EMERGENCY DEPARTMENT VISITS FOR RECURRENT ISCHEMIC PRIAPISM

被引：0
|
作者：
Hou, L. [1 ]
Burnett, A. [1 ]
机构：
[1] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA
来源：
JOURNAL OF SEXUAL MEDICINE | 2021年 / 18卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
122
引用
收藏
页码：S64 / S65
页数：4
相关论文
共 50 条
  • [31] The Association Between Phosphodiesterase Type 5 Inhibitor Use and Risk of Non-Arteritic Anterior Ischemic Optic Neuropathy: A Systematic Review and Meta-Analysis
    Liu, Bing
    Zhu, Linxin
    Zhong, Jingxiang
    Zeng, Guohua
    Deng, Tuo
    SEXUAL MEDICINE, 2018, 6 (03) : 185 - 192
  • [32] Use Of Long-Term Controller Medications At Time Of Discharge Reduces Risk Of Readmission For Asthma-Related Emergency Department Or Inpatient Visits
    Stanford, R. H.
    Buikema, A.
    Riedel, A.
    Camargo, C. A.
    Gomez-Rey, G.
    Chapman, K. R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [33] The Association of Injury With Substance Use Disorder Among Women of Reproductive Age: An Opportunity to Address a Major Contributor to Recurrent Preventable Emergency Department Visits?
    Bernstein, Judith
    Bernstein, Edward
    Belanoff, Candice
    Cabral, Howard J.
    Babakhanlou-Chase, Hermik
    Derrington, Taletha M.
    Diop, Hafsatou
    Douriez, Carole
    Evans, Stephen R.
    Jacobs, Hilary
    Kotelchuck, Milton
    ACADEMIC EMERGENCY MEDICINE, 2014, 21 (12) : 1459 - 1468
  • [34] Proton-pump inhibitor use by coronary artery disease patients is associated with fewer chest pain episodes, emergency department visits and hospitalizations
    Liuzzo, JP
    Ambrose, JA
    Diggs, P
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 22 (02) : 95 - 100
  • [35] Non-Arteritic Anterior Ischemic Optic Neuropathy Associated With the Use of Phosphodiesterase Type 5 Inhibitors: A Literature Review
    Hor, Mosab
    Baradeiya, Ahmed M.
    Qasim, Hodan
    Nasr, Mohamed
    Mohammad, Amad
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (08)
  • [36] Cannabis Use Disorder Emergency Department Visits and Hospitalizations and 5-Year Mortality (vol 8, e2457852, 2025)
    Myran, Daniel T.
    Pugliese, Michael
    McDonald, Andre J.
    Xiao, Jennifer
    Fischer, Benedikt
    Finkelstein, Yaron
    Tanuseputro, Peter
    Firth, Joseph
    Pakpour, Amir
    Hsu, Chih-Wei
    Chang, Wing-Chung
    Solmi, Marco
    JAMA NETWORK OPEN, 2025, 8 (03)
  • [37] P6.11 Phosphodiesterase Type-5 Inhibitor use in Type 2 Diabetes is Associated with a Reduction in All Cause Mortality
    S. Anderson
    D. Hutchings
    C. Kwok
    A. Trafford
    A. Heald
    Artery Research, 2014, 8 (4) : 148 - 148
  • [38] Food and Drug Administration Adverse Event Reports of Retinal Vascular Occlusions Associated With Phosphodiesterase Type 5 Inhibitor Use
    Li, Albert S.
    Pomeranz, Howard D.
    JOURNAL OF NEURO-OPHTHALMOLOGY, 2016, 36 (04) : 480 - 481
  • [39] Phosphodiesterase Type 5 Inhibitor Use Does Not Affect Heart Failure Hospitalizations in Patients with Left Ventricular Assist Devices
    Hassanein, Mohamed T.
    Sheikh, Farooq H.
    Boyce, Steven W.
    Mohammed, Selma F.
    Hofmeyer, Mark
    Majure, David T.
    JOURNAL OF CARDIAC FAILURE, 2017, 23 (08) : S132 - S132
  • [40] The value of the use of plasma B-type natriuretic peptide among acute ischemic stroke patients in a Chinese emergency department
    Wu Zhixin
    Yang Lianhong
    Huang Wei
    Li Lianda
    Jiang Longyuan
    Zhang Yingjian
    Wang Jinliang
    He Mingfeng
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2013, 115 (09) : 1671 - 1676
12345